Category Archives: Burkholderia cepacia

France – VERY ROSE 3-IN-1 SOOTHING MICELLAR WATER – Burkholderia Cepacia

Gov France

Product Category
Hygiene-Beauty
Product subcategory
Cosmetics
Product brand name
NUXE
Model names or references
400 ML BOTTLE
Product identification
GTIN Batch
3264680022050 P124A153-P124A154-P224A154-P124A155-P224B155-P124B156
Packaging
400ML BOTTLE
Start/End of marketing date
From 02/19/2024 to 07/11/2024
Further information
To identify the affected products, refer to the batch number engraved on the bottom of the bottle.
Geographic area of ​​sale
Whole France
Distributors
pharmacies, parapharmacies, online sales, selective distributors

Research – Microbial diversity and prediction function profiling of microbial communities in rose jam

Wiley Online

Abstract

The microbial diversity of rose jam was analyzed by high-throughput sequencing, along with functional prediction of the bacterial community. The results indicate that PseudomonasPantoea, and Burkholderia emerged were the top three dominant bacterial groups. Proteobacteria was particularly abundant in R4 (99.1%) and R6 (96.12%).

Abstract

The microbial diversity of rose jam was analyzed by high-throughput sequencing, along with functional prediction of the bacterial community. The results indicate that PseudomonasPantoea, and Burkholderia emerged were the top three dominant bacterial groups. Proteobacteria was particularly abundant in R4 (99.1%) and R6 (96.12%). Zygosaccharomyces, unclassified fungi, and Botrytis constituted the top three fungal groups. The presence of unclassified OTUs was observed in all samples, particularly in R6 (52.36%), R8 (45.28), and R9 samples (39.57%). Gene prediction using PICRUSt revealed the existence of multiple KEGG functional modules associated with human metabolism in each rose jam sample. The presence of a high abundance of functional genes indicated the microbial community’s diverse wide range of microgenetic resources that can be further explored for research purposes. The microbial community found in rose jam exhibits remarkable diversity and encompasses valuable functional information relevant to human health.

, unclassified fungi, and Botrytis constituted the top three fungal groups. The presence of unclassified OTUs was observed in all samples, particularly in R6 (52.36%), R8 (45.28), and R9 samples (39.57%). Gene prediction using PICRUSt revealed the existence of multiple KEGG functional modules associated with human metabolism in each rose jam sample. The presence of a high abundance of functional genes indicated the microbial community’s diverse wide range of microgenetic resources that can be further explored for research purposes. The microbial community found in rose jam exhibits remarkable diversity and encompasses valuable functional information relevant to human health.

USA – Mavidon Issues Voluntary Worldwide Recall of LemonPrep® Tubes and Single Use Cups

FDA

LemonPrep tubes and cups

Company Announcement

Mavidon is voluntarily recalling 21 lots of LemonPrep® 4 ounce tubes and single use cups to user level. These products have been found to be contaminated with Burkholderia cepacia. The specific lots are listed below:

Product Product # Lot#
LemonPrep 4 oz Tubes MD0019-T 29824, 29901, 30006, 30145, 30236, 30352,
30675, 30729, 31138
LemonPrep Single Use Cups MD0019-SUP 29927, 30009, 30031, 30115, 30059, 30237,
30300, 30340, 30424, 30642, 30735, 31139

Burkholderia cepacia is a multi-drug resistant pathogenic microorganism. Contaminated products with Burkholderia cepacia can potentially result in serious infections, may be life-threatening for patients with compromised immune systems, such as neonates, elderly, pregnant women, cancer patients, but also in previously healthy individuals. To date, Mavidon has received one report of adverse event in a neonate related to this product in recall. Additional testing is ongoing to determine if there are other affected lots.

USA – Multistate Outbreak of Burkholderia cepacia Complex Infections Associated with the Use of Medline Remedy Essentials No-Rinse Cleaning Foam

uuCDC 

 

Update May 21, 2018

CDC is collaborating with the Food and Drug Administration (FDA), state and local health departments, and healthcare facilities to investigate a recent outbreak of Burkholderia cepacia complex (Bcc) infections. As of May 21, 2018, CDC confirmed 15 cases of Bcc infections associated with use of Medline (Northfield, IL) Remedy Essentials No-Rinse Cleansing Foam. Seven infections were in patients in Pennsylvania, seven were in California, and one was in New Jersey. These patients were already hospitalized for acute conditions and acquired the infections while hospitalized.

As of May 8, 2018 FDA is advising health professionals and consumers to avoid using all lots of Medline Remedy Essentials No-Rinse Cleansing foam, manufactured by Shadow Holdings dba Bocchi Laboratories (Santa Clarita, CA), as these products might be contaminated with Bcc. Shadow Holdings dba Bocchi Laboratories has recalled certain lots of the product.

The FDA is investigating this matter further to determine whether any additional products or lots may present a risk to consumers.

B. cepacia complex bacteria are environmental pathogens. Infections can be transmitted through infection control lapses, including indirect contact via environmental surfaces. Person-to-person transmission is possible but less common. B. cepacia complex bacteria can grow in aqueous environments, can exhibit resistance to preservatives, and can cause contamination of liquid medications or other liquid products. These factors have led to previous healthcare-associated outbreaks of B. cepacia complex. For additional information on B. cepacia complex bacteria please visit: Burkholderia cepacia in Healthcare Settings(https://www.cdc.gov/hai/organisms/bcepacia.html).

Report adverse reactions or quality problems experienced with the use of this product to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

The product recall notice and list of products can be found here: Medline Canada, Corp. recalls Remedy Essentials Foaming Cleanser

FDA Alert May 7, 2018 – Multistate Outbreak of Burkholderia cepacia Infections Associated with the Use of Medline Remedy Essentials No-Rinse Cleaning Foam  

Additional updates will be posted as they become available.

USA – FDA Investigates Multistate Outbreak of B. cepacia Complex Linked to Medline Remedy Essentials No-Rinse Cleansing Foam (FDA Announcement)

FDA 

 

Fast Facts

  • The FDA is advising health professionals and consumers to avoid using all lots of Medline Remedy Essentials No-Rinse Cleansing Foam, manufactured by Shadow Holdings dba Bocchi Laboratories at this time, as these products might be contaminated with several species within the bacteria, Burkholderia cepacia complex (Bcc).
  • Shadow Holdings dba Bocchi Laboratories has recalled certain lots of the product.
  • The FDA is investigating whether other products manufactured by Shadow Holdings dba Bocchi Laboratories may be contaminated with, Bcc, and may present a risk to consumers.
  • As of May 7, 2018, CDC reports that there are 10 confirmed cases of Bcc associated with use of Medline Remedy Essentials No-Rinse Cleansing Foam (seven in Pennsylvania, one in New Jersey and two in California). These patients were already hospitalized for acute conditions and acquired the infections while hospitalized.
  • This cleansing foam is a product used for skin and perineal care. It is used in hospitals and home-health care settings for people who are unable to shower or bathe after surgery or due to other acute health conditions. FDA is particularly concerned about contamination in this product, since product instructions do not include rinsing the product from patient skin. This poses a risk to persons who might be immunocompromised or have other underlying medical conditions.
  • State and federal health officials have collected samples of the product from multiple locations, including affected hospitals. As of May 7, 2018, there have been multiple product samples that tested positive for Bcc. Isolates from these product samples match clinical strains isolated from case patients by Pulsed Field Gel Electrophoresis (PFGE). Additionally, an environmental swab collected at Shadow Holdings, dba Bocchi Laboratories during FDA’s investigation has tested positive for a strain of Bcc. Given these positive samples, the FDA is advising the public to not use any Medline Remedy Essentials No-Rinse Cleansing Foam products at this time.
  • The FDA will update the public with more information as it becomes available.